Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy.

Caster JM, Callaghan C, Seyedin SN, Henderson K, Sun B, Wang AZ.

Adv Drug Deliv Rev. 2019 Jul 19. pii: S0169-409X(19)30119-X. doi: 10.1016/j.addr.2019.07.009. [Epub ahead of print]

PMID:
31330165
2.

[Natural science research in Changbai Mountain during 1956-2018:A review.]

Liu YG, Zhang ML, Guan X, Song XF, Yuan FH, Wu JB, Wang AZ.

Ying Yong Sheng Tai Xue Bao. 2019 May;30(5):1783-1796. doi: 10.13287/j.1001-9332.201905.003. Review. Chinese.

PMID:
31107035
3.

[Measuring and calculating methods of plant mesophyll conductance: A review.]

Zhu K, Yuan FH, Guan X, Wu JB, Wang AZ.

Ying Yong Sheng Tai Xue Bao. 2019 May;30(5):1772-1782. doi: 10.13287/j.1001-9332.201905.002. Review. Chinese.

PMID:
31107034
4.

[Characteristics of climate change in Changbai Mountain ecological functional area, Northeast China.]

Liu YG, Yuan FH, Wang AZ, Wu JB, Zheng XB, Yin H, Guan X.

Ying Yong Sheng Tai Xue Bao. 2019 May;30(5):1503-1512. doi: 10.13287/j.1001-9332.201905.006. Chinese.

PMID:
31107005
5.

[Stable carbon isotopic characteristics of plant-litter-soil continuum along a successional gradient of broadleaved Korean pine forests in Changbai Mountain, China.]

Diao HY, Wang AZ, Yuan FH, Guan X, Yin H, Wu JB.

Ying Yong Sheng Tai Xue Bao. 2019 May;30(5):1435-1444. doi: 10.13287/j.1001-9332.201905.007. Chinese.

PMID:
31106997
6.

Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.

Tian X, Werner ME, Roche KC, Hanson AD, Foote HP, Yu SK, Warner SB, Copp JA, Lara H, Wauthier EL, Caster JM, Herring LE, Zhang L, Tepper JE, Hsu DS, Zhang T, Reid LM, Wang AZ.

Nat Biomed Eng. 2018 Jun;2(6):443-452. doi: 10.1038/s41551-018-0231-0. Epub 2018 Apr 23.

PMID:
31011191
7.

Gamblers: An Antibiotic-Induced Evolvable Cell Subpopulation Differentiated by Reactive-Oxygen-Induced General Stress Response.

Pribis JP, García-Villada L, Zhai Y, Lewin-Epstein O, Wang AZ, Liu J, Xia J, Mei Q, Fitzgerald DM, Bos J, Austin RH, Herman C, Bates D, Hadany L, Hastings PJ, Rosenberg SM.

Mol Cell. 2019 May 16;74(4):785-800.e7. doi: 10.1016/j.molcel.2019.02.037. Epub 2019 Apr 1.

PMID:
30948267
8.

Emerging Nano-/Microapproaches for Cancer Immunotherapy.

Mi Y, Hagan CT 4th, Vincent BG, Wang AZ.

Adv Sci (Weinh). 2019 Jan 13;6(6):1801847. doi: 10.1002/advs.201801847. eCollection 2019 Mar 20. Review.

9.

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.

Sanoff HK, Moon DH, Moore DT, Boles J, Bui C, Blackstock W, O'Neil BH, Subramaniam S, McRee AJ, Carlson C, Lee MS, Tepper JE, Wang AZ.

Nanomedicine. 2019 Jun;18:189-195. doi: 10.1016/j.nano.2019.02.021. Epub 2019 Mar 8.

PMID:
30858085
10.
11.

Leptin ameliorates the immunity, but not reproduction, trade-off with endurance in lizards.

Wang AZ, Husak JF, Lovern M.

J Comp Physiol B. 2019 Apr;189(2):261-269. doi: 10.1007/s00360-019-01202-2. Epub 2019 Jan 21.

PMID:
30666396
12.

Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience.

Tahover E, Bar-Shalom R, Sapir E, Pfeffer R, Nemirovsky I, Turner Y, Gips M, Ohana P, Corn BW, Wang AZ, Gabizon AA.

Front Oncol. 2018 Nov 26;8:544. doi: 10.3389/fonc.2018.00544. eCollection 2018.

13.

Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.

Tian X, Werner ME, Roche KC, Hanson AD, Foote HP, Yu SK, Warner SB, Copp JA, Lara H, Wauthier EL, Caster JM, Herring LE, Zhang L, Tepper JE, Hsu DS, Zhang T, Reid LM, Wang AZ.

Nat Biomed Eng. 2018;2:443-452. Epub 2018 Apr 23.

14.

Fluorescent fusions of the N protein of phage Mu label DNA damage in living cells.

Kotlajich MV, Xia J, Zhai Y, Lin HY, Bradley CC, Shen X, Mei Q, Wang AZ, Lynn EJ, Shee C, Chen LT, Li L, Miller KM, Herman C, Hastings PJ, Rosenberg SM.

DNA Repair (Amst). 2018 Dec;72:86-92. doi: 10.1016/j.dnarep.2018.09.005. Epub 2018 Sep 14.

15.

Advancing the Pharmaceutical Potential of Bioinorganic Hybrid Lipid-Based Assemblies.

Wang J, Wang AZ, Lv P, Tao W, Liu G.

Adv Sci (Weinh). 2018 Jul 20;5(9):1800564. doi: 10.1002/advs.201800564. eCollection 2018 Sep. Review.

16.

Ultrasound-guided posterior ramus of spinal nerve block for anesthesia and analgesia in lumbar spinal surgery.

Wang AZ, Fan K.

J Clin Anesth. 2019 Feb;52:48-49. doi: 10.1016/j.jclinane.2018.08.032. Epub 2018 Aug 31. No abstract available.

PMID:
30176503
17.

RUNX1 upregulation via disruption of long-range transcriptional control by a novel t(5;21)(q13;q22) translocation in acute myeloid leukemia.

Cheng CK, Wong THY, Wan TSK, Wang AZ, Chan NPH, Chan NCN, Li CK, Ng MHL.

Mol Cancer. 2018 Aug 29;17(1):133. doi: 10.1186/s12943-018-0881-2.

18.

A lateral approach to ultrasound-guided sacral plexus block in the supine position.

Wang AZ, Fan K, Zhou QH, Wang C, Niu Q, Chan Y.

Anaesthesia. 2018 Aug;73(8):1043-1044. doi: 10.1111/anae.14368. No abstract available.

19.

Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study.

Holmes JA, Anderson RF, Hoffman LG, Showalter TN, Kasibhatla M, Collins SP, Papagikos MA, Barbosa BD, Alligood K, Stravers LJ, Mahbooba Z, Wang AZ, Chen RC.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):112-115. doi: 10.1016/j.ijrobp.2018.07.2018. Epub 2018 Aug 9.

PMID:
30099132
20.

Nanotechnology Approaches to Improving Cancer Immunotherapy.

Hagan CT 4th, Medik YB, Wang AZ.

Adv Cancer Res. 2018;139:35-56. doi: 10.1016/bs.acr.2018.05.003. Epub 2018 Jun 7.

PMID:
29941106
21.

Ultrasound-guided multiple nerve block with a small volume local anesthetic at each site for radical mastectomy in day surgery.

Wang AZ, Fan K, Niu Q.

J Clin Anesth. 2018 Sep;49:44-45. doi: 10.1016/j.jclinane.2018.06.008. Epub 2018 Jun 7. No abstract available.

PMID:
29886269
22.

Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers.

Hong S, Wang AZ.

Adv Drug Deliv Rev. 2018 Feb 1;125:1-2. doi: 10.1016/j.addr.2018.04.014. No abstract available.

PMID:
29880212
23.

A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy.

Mi Y, Smith CC, Yang F, Qi Y, Roche KC, Serody JS, Vincent BG, Wang AZ.

Adv Mater. 2018 Jun;30(25):e1706098. doi: 10.1002/adma.201706098. Epub 2018 Apr 25.

24.

Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.

Zhang M, Hagan CT 4th, Min Y, Foley H, Tian X, Yang F, Mi Y, Au KM, Medik Y, Roche K, Wagner K, Rodgers Z, Wang AZ.

Biomaterials. 2018 Jul;169:1-10. doi: 10.1016/j.biomaterials.2018.03.055. Epub 2018 Mar 31.

25.

Clinical indications for, and the future of, circulating tumor cells.

Moon DH, Lindsay DP, Hong S, Wang AZ.

Adv Drug Deliv Rev. 2018 Feb 1;125:143-150. doi: 10.1016/j.addr.2018.04.002. Epub 2018 Apr 5. Review.

PMID:
29626548
26.

Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins.

Bloomquist CJ, Mecham MB, Paradzinsky MD, Janusziewicz R, Warner SB, Luft JC, Mecham SJ, Wang AZ, DeSimone JM.

J Control Release. 2018 May 28;278:9-23. doi: 10.1016/j.jconrel.2018.03.026. Epub 2018 Mar 27.

PMID:
29596874
27.

Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture.

Myung JH, Eblan MJ, Caster JM, Park SJ, Poellmann MJ, Wang K, Tam KA, Miller SM, Shen C, Chen RC, Zhang T, Tepper JE, Chera BS, Wang AZ, Hong S.

Clin Cancer Res. 2018 Jun 1;24(11):2539-2547. doi: 10.1158/1078-0432.CCR-17-3078. Epub 2018 Mar 15.

28.

Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer.

Wan X, Min Y, Bludau H, Keith A, Sheiko SS, Jordan R, Wang AZ, Sokolsky-Papkov M, Kabanov AV.

ACS Nano. 2018 Mar 27;12(3):2426-2439. doi: 10.1021/acsnano.7b07878. Epub 2018 Mar 16.

29.

Energetic costs of performance in trained and untrained Anolis carolinensis lizards.

Lailvaux SP, Wang AZ, Husak JF.

J Exp Biol. 2018 Apr 23;221(Pt 8). pii: jeb176867. doi: 10.1242/jeb.176867.

30.

Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.

Mavroidis P, Pearlstein KA, Dooley J, Sun J, Saripalli S, Das SK, Wang AZ, Chen RC.

Radiat Oncol. 2018 Feb 2;13(1):17. doi: 10.1186/s13014-018-0961-x.

31.

A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.

Moon DH, Wang AZ, Tepper JE.

Radiother Oncol. 2018 Mar;126(3):527-533. doi: 10.1016/j.radonc.2018.01.004. Epub 2018 Jan 30.

PMID:
29366521
32.

Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma.

Au KM, Tripathy A, Lin CP, Wagner K, Hong S, Wang AZ, Park SI.

ACS Nano. 2018 Feb 27;12(2):1544-1563. doi: 10.1021/acsnano.7b08122. Epub 2018 Jan 26.

PMID:
29361211
33.

Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

Hartshorn CM, Bradbury MS, Lanza GM, Nel AE, Rao J, Wang AZ, Wiesner UB, Yang L, Grodzinski P.

ACS Nano. 2018 Jan 23;12(1):24-43. doi: 10.1021/acsnano.7b05108. Epub 2017 Dec 22. Review.

34.

Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs).

Myung JH, Park SJ, Wang AZ, Hong S.

Adv Drug Deliv Rev. 2018 Feb 1;125:36-47. doi: 10.1016/j.addr.2017.12.005. Epub 2017 Dec 13. Review.

PMID:
29247765
35.

Mapping and comparative proteomic analysis of the starch biosynthetic pathway in rice by 2D PAGE/MS.

Chang TS, Liu CW, Lin YL, Li CY, Wang AZ, Chien MW, Wang CS, Lai CC.

Plant Mol Biol. 2017 Nov;95(4-5):333-343. doi: 10.1007/s11103-017-0652-2. Epub 2017 Sep 8.

PMID:
28887709
36.

Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models.

Tian J, Min Y, Rodgers Z, Au KM, Hagan CT 4th, Zhang M, Roche K, Yang F, Wagner K, Wang AZ.

J Mater Chem B. 2017 Aug 14;5(30):6049-6057. doi: 10.1039/C7TB01370A. Epub 2017 Jul 5.

37.

Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.

Caster JM, Wang AZ.

Ther Deliv. 2017 Aug;8(9):791-803. doi: 10.4155/tde-2017-0043. Review.

PMID:
28825397
38.

Rac2 deficiency attenuates CCl4-induced liver injury through suppressing inflammation and oxidative stress.

Zou Y, Xiong JB, Ma K, Wang AZ, Qian KJ.

Biomed Pharmacother. 2017 Oct;94:140-149. doi: 10.1016/j.biopha.2017.07.074. Epub 2017 Jul 28.

PMID:
28759751
39.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.

Min Y, Roche KC, Tian S, Eblan MJ, McKinnon KP, Caster JM, Chai S, Herring LE, Zhang L, Zhang T, DeSimone JM, Tepper JE, Vincent BG, Serody JS, Wang AZ.

Nat Nanotechnol. 2017 Sep;12(9):877-882. doi: 10.1038/nnano.2017.113. Epub 2017 Jun 26.

40.

Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody.

Wang C, Sun W, Wright G, Wang AZ, Gu Z.

Adv Mater. 2017 Apr;29(15). doi: 10.1002/adma.201700761. No abstract available.

PMID:
28407370
41.

FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.

Cheng CK, Wang AZ, Wong THY, Wan TSK, Cheung JS, Raghupathy R, Chan NPH, Ng MHL.

Blood. 2017 May 11;129(19):2705-2709. doi: 10.1182/blood-2017-02-767707. Epub 2017 Mar 17. No abstract available.

42.

Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy.

Caster JM, Yu SK, Patel AN, Newman NJ, Lee ZJ, Warner SB, Wagner KT, Roche KC, Tian X, Min Y, Wang AZ.

Nanomedicine. 2017 Jul;13(5):1673-1683. doi: 10.1016/j.nano.2017.03.002. Epub 2017 Mar 11.

43.

Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.

Lee MS, Dees EC, Wang AZ.

Oncology (Williston Park). 2017 Mar 15;31(3):198-208. Review.

44.

Nanomedicine approaches to improve cancer immunotherapy.

Qiu H, Min Y, Rodgers Z, Zhang L, Wang AZ.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5). doi: 10.1002/wnan.1456. Epub 2017 Mar 10. Review.

45.

Patient-reported quality of life during definitive and postprostatectomy image-guided radiation therapy for prostate cancer.

Diao K, Lobos EA, Yirmibesoglu E, Basak R, Hendrix LH, Barbosa B, Miller SM, Pearlstein KA, Goldin GH, Wang AZ, Chen RC.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):e117-e124. doi: 10.1016/j.prro.2016.08.004. Epub 2016 Aug 12.

PMID:
28274402
46.

Application of nanotechnology to cancer radiotherapy.

Mi Y, Shao Z, Vang J, Kaidar-Person O, Wang AZ.

Cancer Nanotechnol. 2016;7(1):11. doi: 10.1186/s12645-016-0024-7. Epub 2016 Dec 19. Review.

47.

Bio-nano interface: The impact of biological environment on nanomaterials and their delivery properties.

Cai K, Wang AZ, Yin L, Cheng J.

J Control Release. 2017 Oct 10;263:211-222. doi: 10.1016/j.jconrel.2016.11.034. Epub 2017 Jan 3. Review.

PMID:
28062299
48.

Poor Consumer Comprehension and Plan Selection Inconsistencies Under the 2016 HealthCare.gov Choice Architecture.

Wang AZ, Scherr KA, Wong CA, Ubel PA.

MDM Policy Pract. 2017 Jan-Jun;2(1). doi: 10.1177/2381468317716441. Epub 2017 Jun 28.

49.

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer.

Rose TL, Deal AM, Ladoire S, Créhange G, Galsky MD, Rosenberg JE, Bellmunt J, Wimalasingham A, Wong YN, Harshman LC, Chowdhury S, Niegisch G, Liontos M, Yu EY, Pal SK, Chen RC, Wang AZ, Nielsen ME, Smith AB, Milowsky MI; Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.

Bladder Cancer. 2016 Oct 27;2(4):405-413. doi: 10.3233/BLC-160072.

50.

Co-delivery of all-trans-retinoic acid enhances the anti-metastasis effect of albumin-bound paclitaxel nanoparticles.

Huang H, Shi H, Liu J, Min Y, Wang Y, Wang AZ, Wang J, Liu Y.

Chem Commun (Camb). 2016 Dec 20;53(1):212-215.

PMID:
27918025

Supplemental Content

Support Center